MeSH term
Frequency | Condition_Probility | Animals | 91 | 0.0 |
Base Sequence | 43 | 0.0 |
Cell Line, Tumor | 7 | 0.0 |
Cells, Cultured | 17 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 10 | 1.0 |
Humans | 141 | 0.0 |
Melanocytes/cytology/metabolism | 2 | 20.0 |
Melanoma/genetics/metabolism/pathology | 3 | 60.0 |
Mice | 69 | 0.0 |
NIH 3T3 Cells | 4 | 1.0 |
Phosphorylation | 8 | 0.0 |
Protein Binding | 21 | 0.0 |
Research Support, Non-U.S. Gov't | 96 | 0.0 |
*Trans-Activation (Genetics) | 4 | 0.0 |
Transcription Factors/genetics/*metabolism | 7 | 0.0 |
Treatment Outcome | 2 | 0.0 |
DNA-Binding Proteins/metabolism | 3 | 0.0 |
Enzyme Activation | 2 | 0.0 |
Melanins/*biosynthesis | 5 | 31.0 |
Monophenol Monooxygenase/genetics | 9 | 42.0 |
Promoter Regions (Genetics) | 32 | 0.0 |
*Protein-Serine-Threonine Kinases | 2 | 0.0 |
Proto-Oncogene Proteins/metabolism | 2 | 0.0 |
Transcription Factors/metabolism | 4 | 0.0 |
Tumor Cells, Cultured | 23 | 0.0 |
Chromatin/metabolism | 2 | 0.0 |
Cycloheximide/pharmacology | 3 | 0.0 |
DNA-Binding Proteins/*metabolism | 7 | 0.0 |
Gene Expression Regulation | 8 | 0.0 |
Melanocytes/*metabolism | 11 | 27.0 |
Models, Genetic | 5 | 0.0 |
Oligonucleotide Array Sequence Analysis | 3 | 0.0 |
Osteoclasts/metabolism | 4 | 18.0 |
Phenotype | 11 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 43 | 0.0 |
Signal Transduction | 10 | 0.0 |
Time Factors | 5 | 0.0 |
*Transcription Factors | 41 | 2.0 |
Transcription, Genetic | 21 | 0.0 |
Binding Sites | 8 | 0.0 |
COS Cells | 7 | 0.0 |
Cell Nucleus/metabolism | 3 | 0.0 |
DNA-Binding Proteins/*chemistry/genetics/*metabolism | 2 | 3.0 |
Dose-Response Relationship, Drug | 4 | 0.0 |
Genes, Dominant | 7 | 0.0 |
Hela Cells | 11 | 0.0 |
Luciferases/metabolism | 7 | 1.0 |
Mutation | 26 | 0.0 |
Plasmids/metabolism | 5 | 0.0 |
*Promoter Regions (Genetics) | 7 | 0.0 |
Protein Isoforms | 4 | 0.0 |
Protein Structure, Tertiary | 8 | 0.0 |
Trans-Activation (Genetics) | 19 | 1.0 |
Transcription Factors/*metabolism | 7 | 0.0 |
Transfection | 25 | 0.0 |
Cell Differentiation | 11 | 0.0 |
*Signal Transduction | 3 | 0.0 |
Mast Cells/*metabolism | 2 | 5.0 |
Molecular Sequence Data | 46 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 17 | 0.0 |
Genes, Reporter | 10 | 0.0 |
Luciferases/genetics/metabolism | 5 | 2.0 |
RNA, Messenger/genetics | 5 | 0.0 |
Adolescent | 8 | 0.0 |
DNA-Binding Proteins/biosynthesis | 2 | 2.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Kinetics | 2 | 0.0 |
Monophenol Monooxygenase/metabolism | 4 | 21.0 |
Transcription Factors/biosynthesis | 2 | 2.0 |
Amino Acid Sequence | 21 | 0.0 |
Blotting, Western | 6 | 0.0 |
DNA, Complementary/metabolism | 2 | 0.0 |
Intramolecular Oxidoreductases/genetics | 3 | 60.0 |
Models, Biological | 5 | 0.0 |
Proto-Oncogene Proteins/*metabolism | 2 | 0.0 |
Two-Hybrid System Techniques | 2 | 0.0 |
*Zebrafish Proteins | 4 | 1.0 |
Adult | 18 | 0.0 |
Cell Line | 14 | 0.0 |
Comparative Study | 20 | 0.0 |
Exons | 8 | 0.0 |
Macrophages/metabolism | 2 | 0.0 |
Male | 32 | 0.0 |
Pigment Epithelium of Eye/*metabolism | 2 | 6.0 |
Monophenol Monooxygenase/analysis | 3 | 42.0 |
Neoplasm Proteins/analysis | 3 | 0.0 |
S100 Proteins/analysis | 5 | 2.0 |
Tumor Markers, Biological/analysis | 5 | 0.0 |
Alleles | 9 | 0.0 |
DNA-Binding Proteins/chemistry/genetics/*physiology | 2 | 5.0 |
Dimerization | 3 | 0.0 |
Mice, Inbred C57BL | 10 | 0.0 |
Osteoclasts/*physiology | 2 | 10.0 |
Transcription Factors/chemistry/genetics/*physiology | 2 | 7.0 |
Cloning, Molecular | 12 | 0.0 |
DNA-Binding Proteins/genetics/*physiology | 7 | 3.0 |
Mast Cells/*physiology | 2 | 12.0 |
DNA-Binding Proteins/*physiology | 9 | 1.0 |
Neoplasm Metastasis | 2 | 0.0 |
Aged | 8 | 0.0 |
DNA Primers | 6 | 0.0 |
DNA-Binding Proteins/*genetics | 22 | 1.0 |
Female | 30 | 0.0 |
Melanocytes/metabolism | 7 | 17.0 |
Middle Aged | 11 | 0.0 |
Neoplasm Proteins/genetics | 2 | 0.0 |
RNA, Neoplasm/analysis | 2 | 0.0 |
Transcription Factors/genetics | 8 | 0.0 |
Helix-Loop-Helix Motifs | 12 | 5.0 |
Promoter Regions (Genetics)/genetics | 7 | 0.0 |
Protein Isoforms/genetics | 3 | 1.0 |
Transcription Factors/*genetics | 13 | 0.0 |
Chromosome Mapping | 8 | 0.0 |
DNA-Binding Proteins/genetics | 7 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
*Mutation | 6 | 0.0 |
Pedigree | 10 | 0.0 |
Waardenburg's Syndrome/*genetics | 12 | 31.0 |
Child, Preschool | 3 | 0.0 |
Immunohistochemistry | 16 | 0.0 |
Syndrome | 4 | 0.0 |
*Gene Expression Regulation | 8 | 0.0 |
Waardenburg's Syndrome/genetics | 6 | 28.0 |
Deafness/genetics | 6 | 13.0 |
Melanocytes/*physiology | 3 | 33.0 |
Melanoma/*immunology/pathology | 2 | 8.0 |
3T3 Cells | 5 | 0.0 |
Blotting, Northern | 7 | 0.0 |
Green Fluorescent Proteins | 3 | 0.0 |
Jurkat Cells | 2 | 0.0 |
Luminescent Proteins/metabolism | 3 | 0.0 |
Precipitin Tests | 4 | 0.0 |
RNA, Messenger/metabolism | 4 | 0.0 |
Evolution, Molecular | 4 | 0.0 |
Gene Expression | 6 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 5 | 0.0 |
Receptors, Melanocortin | 2 | 2.0 |
Recombinant Fusion Proteins/genetics/metabolism | 3 | 0.0 |
Sequence Analysis, DNA | 4 | 0.0 |
Sequence Homology, Nucleic Acid | 9 | 0.0 |
Point Mutation | 3 | 0.0 |
Transcription Factors/*physiology | 8 | 1.0 |
Melanoma/metabolism | 4 | 14.0 |
*Membrane Transport Proteins | 2 | 0.0 |
Pigmentation | 3 | 21.0 |
RNA, Messenger/analysis | 2 | 0.0 |
*Transcription, Genetic | 3 | 0.0 |
Amino Acid Motifs | 2 | 0.0 |
Cell Differentiation/physiology | 2 | 0.0 |
Mice, Inbred Strains | 4 | 0.0 |
DNA-Binding Proteins/*analysis | 5 | 8.0 |
Sensitivity and Specificity | 7 | 0.0 |
Skin Neoplasms/*pathology | 3 | 3.0 |
Transcription Factors/*analysis | 2 | 3.0 |
Tumor Markers, Biological/*analysis | 3 | 0.0 |
Antibodies, Monoclonal/*diagnostic use | 2 | 0.0 |
Melanoma/*pathology | 2 | 3.0 |
In Situ Hybridization | 4 | 0.0 |
Phylogeny | 2 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Melanocytes/pathology | 3 | 16.0 |
Biological Markers/analysis | 3 | 0.0 |
DNA-Binding Proteins/*genetics/metabolism | 7 | 1.0 |
Melanins/metabolism | 2 | 8.0 |
*Membrane Glycoproteins | 10 | 1.0 |
*Oxidoreductases | 12 | 15.0 |
Proteins/genetics | 3 | 0.0 |
Actins/analysis | 2 | 1.0 |
DNA-Binding Proteins/*genetics/*metabolism | 3 | 2.0 |
Genotype | 4 | 0.0 |
Heterozygote | 2 | 0.0 |
Recombinant Proteins/metabolism | 4 | 0.0 |
Binding Sites/genetics | 3 | 0.0 |
DNA Mutational Analysis | 4 | 0.0 |
Melanocytes/cytology/*metabolism | 5 | 45.0 |
Leucine Zippers | 7 | 4.0 |
Mutagenesis, Site-Directed | 4 | 0.0 |
Sequence Deletion | 4 | 0.0 |
Diagnosis, Differential | 6 | 0.0 |
English Abstract | 5 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Neoplasm Proteins/*analysis | 3 | 0.0 |
DNA | 2 | 0.0 |
Gene Expression Regulation, Enzymologic/*physiology | 3 | 3.0 |
Transcription, Genetic/physiology | 2 | 1.0 |
Tetradecanoylphorbol Acetate/pharmacology | 2 | 0.0 |
Up-Regulation | 5 | 0.0 |
Cell Division | 2 | 0.0 |
Immunoblotting | 2 | 0.0 |
Infant, Newborn | 4 | 0.0 |
Pigmentation/genetics | 2 | 16.0 |
Protein Biosynthesis | 2 | 0.0 |
alpha-MSH/*metabolism | 2 | 40.0 |
Melanoma/*metabolism/pathology | 2 | 5.0 |
Neoplasm Proteins/*metabolism | 2 | 0.0 |
Cell Transformation, Neoplastic | 2 | 0.0 |
Mast Cells/pathology | 3 | 8.0 |
Proto-Oncogene Protein c-kit/genetics | 4 | 11.0 |
Child | 6 | 0.0 |
Proto-Oncogene Protein c-kit/*genetics | 2 | 4.0 |
Bone Marrow Cells | 2 | 0.0 |
Genomic Library | 3 | 0.0 |
Nuclear Proteins/metabolism | 4 | 0.0 |
*Leucine Zippers | 4 | 8.0 |
Melanosomes/*metabolism | 2 | 20.0 |
Conserved Sequence | 3 | 0.0 |
DNA-Binding Proteins/biosynthesis/*genetics | 3 | 2.0 |
Gene Deletion | 2 | 0.0 |
High Mobility Group Proteins/biosynthesis/*genetics | 2 | 16.0 |
Mice, Inbred C3H | 3 | 0.0 |
Mice, Mutant Strains | 10 | 1.0 |
Mutagenesis | 3 | 0.0 |
Lod Score | 4 | 0.0 |
Microphthalmos/*genetics | 9 | 42.0 |
High Mobility Group Proteins/*genetics/metabolism | 2 | 15.0 |
Transcription Factors/*genetics/metabolism | 2 | 0.0 |
Waardenburg's Syndrome/*genetics/metabolism | 2 | 100.0 |
Endothelin-3/genetics | 2 | 15.0 |
Epistasis, Genetic | 2 | 3.0 |
Frameshift Mutation | 2 | 0.0 |
Transcription Factors/genetics/metabolism | 3 | 0.0 |
DNA-Binding Proteins/metabolism/*physiology | 3 | 2.0 |
Pigment Epithelium of Eye/metabolism | 3 | 10.0 |
RNA/metabolism | 3 | 0.0 |
Tissue Distribution | 2 | 0.0 |
Transcription Factors/metabolism/*physiology | 4 | 4.0 |
Linkage (Genetics)/genetics | 2 | 0.0 |
Cyclic AMP/*metabolism | 2 | 0.0 |
Alternative Splicing | 3 | 0.0 |
Gene Expression Regulation, Developmental | 6 | 0.0 |
Melanocytes/cytology/*physiology | 2 | 50.0 |
Transcription Factors/physiology | 3 | 1.0 |
Trans-Activators/genetics/metabolism | 2 | 1.0 |
*Gene Expression Regulation, Neoplastic | 5 | 0.0 |
Melanins/biosynthesis | 2 | 10.0 |
Amino Acid Substitution | 2 | 0.0 |
Monophenol Monooxygenase/genetics/metabolism | 5 | 71.0 |
Recombinant Proteins/genetics/metabolism | 3 | 0.0 |
Helix-Loop-Helix Motifs/*genetics | 4 | 10.0 |
Leucine Zippers/*genetics | 3 | 14.0 |
Korea | 2 | 0.0 |
Helix-Loop-Helix Motifs/genetics | 2 | 5.0 |
Leucine Zippers/genetics | 3 | 6.0 |
Pigmentation Disorders/genetics | 4 | 28.0 |
Hearing Loss, Sensorineural/genetics | 2 | 11.0 |
Chromosomes, Human, Pair 3 | 4 | 2.0 |
Genetic Markers | 5 | 0.0 |
Linkage (Genetics) | 3 | 0.0 |
Disease Models, Animal | 4 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 4 | 0.0 |
Acetamides/pharmacology | 2 | 16.0 |
Melanoma | 2 | 2.0 |
Restriction Mapping | 2 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Microphthalmos/genetics | 2 | 28.0 |
Waardenburg's Syndrome/*genetics/pathology | 2 | 66.0 |
DNA-Binding Proteins/genetics/metabolism/*physiology | 2 | 3.0 |
Homozygote | 2 | 0.0 |
Introns | 2 | 0.0 |
*Neoplasm Proteins | 5 | 0.0 |
Stem Cells/cytology/physiology | 2 | 9.0 |
Genetic Heterogeneity | 2 | 0.0 |
Gene Expression Profiling | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 2 | 0.0 |
*Translocation, Genetic | 3 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Rats | 2 | 0.0 |
Prognosis | 2 | 0.0 |
Infant | 2 | 0.0 |
Monophenol Monooxygenase/*genetics | 3 | 12.0 |
*Helix-Loop-Helix Motifs | 3 | 3.0 |
Melanocytes/*cytology | 2 | 25.0 |
RNA | 2 | 4.0 |
Transcription Factors/genetics/*physiology | 3 | 1.0 |
Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Proteins/*genetics | 2 | 0.0 |
DNA-Binding Proteins/chemistry/genetics/*metabolism | 2 | 1.0 |
Transcription Factors/chemistry/genetics/*metabolism | 2 | 1.0 |
*Mucins | 2 | 2.0 |
*Muscle Proteins | 2 | 0.0 |
*Neuropeptides | 2 | 1.0 |
DNA-Binding Proteins/chemistry/*genetics | 2 | 2.0 |
Sequence Homology | 2 | 0.0 |
Species Specificity | 3 | 0.0 |
DNA-Binding Proteins/physiology | 2 | 0.0 |
Mice, Transgenic | 2 | 0.0 |
Enhancer Elements (Genetics) | 2 | 0.0 |
Eye Color/genetics | 3 | 33.0 |
Hair Color/genetics | 2 | 11.0 |
*Chromosomes, Human, Pair 3 | 2 | 0.0 |
Trans-Activators/*physiology | 2 | 0.0 |
Disease Progression | 2 | 0.0 |
Melanoma/*genetics/metabolism/pathology | 2 | 12.0 |
Down-Regulation | 2 | 0.0 |
Carrier Proteins/*physiology | 2 | 0.0 |
Electrophoretic Mobility Shift Assay | 2 | 0.0 |
Genetic Vectors | 2 | 0.0 |
Membrane Glycoproteins/genetics/*metabolism | 2 | 1.0 |
Gene Expression Regulation/drug effects | 2 | 0.0 |
